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Seasonal affective disorder (SAD) is a state of depression induced by a lack of 
sufficient sunlight that occurs at high latitudes during the fall and winter. One 
effect of SAD is that causes people to be more risk-adverse, an effect that 
should be considered by granting agencies of high latitude countries. Funding 
agencies often have programmes aimed at high-risk, innovative research. 
However, the time of the year during which these purposefully high-risk 
proposals are evaluated usually does not take into consideration the effects of 
SAD. In high-latitude countries (e.g., Canada, UK, Nordic and Baltic countries), 
evaluating proposals for high-risk programmes during the late fall might 
significantly detract from the very purpose of such programmes. At this time of 
the year, grant evaluators might be in a darkness-induced state of mild 
depression. As such, evaluators might be more likely to opt for safe 
investments, more of the same, the well established, which is the antithesis of 
innovative research. 
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Seasonal affective disorder (SAD) is a state of depression induced by a lack of 
sufficient sunlight that occurs in people living at high latitudes during the fall and winter. The 
symptoms are typical of most forms of depression. Physical symptoms include lethargy, 
inability to concentrate, increased sleeping and eating, lack of activity, and weight gain. 
Psychological symptoms include irritability, sadness, pessimism, guilt, worthlessness, lack of 
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creativity, low sex drive, increased thoughts of suicide, and loss of interest in hobbies and 
social activities [1,2]. SAD can affect up to 10-15% of the population, and it is generally more 
prevalent at higher latitudes [3]. Sub-clinical symptoms occur in at least as many people [4], 
so clinical SAD is  just a extreme case of an otherwise relatively common condition. 
Depression leads to risk-aversion in investment decisions [5]; SAD-induced 
depression has the same effect. For instance, seasonal cycles in stock markets, and a 6 month 
shift between market cycles in the 2 hemispheres, are both consistent with the hypothesis that 
investors are most risk-averse in the fall and winter, and most risk-prone in the spring and 
summer [6]. Similarly, initial public offerings (IPOs) in the U.S.A. are relatively underpriced 
in the fall and winter compared to in the summer and spring [7]. Also, stock analysts in the 
USA are significantly less optimistic about their forecasts during SAD months than the rest of 
the year, more so in northern states [8]. In a laboratory setting, people who are affected by 
SAD are significantly more likely than control individuals to avoid risk in financial decisions, 
but only during the winter [9]. Fluctuations in the stock market are driven by individual 
decisions of million of people; hence, it is apparent that clinical and sub-clinical forms of 
SAD are strong enough to affect decision-making in the general population. 
One might think that this information is important only to investors and CEOs, but at 
least one other group should heed these results: granting agencies in high-latitude countries. 
Investing and grant evaluation are similar processes. In both cases, assessors, whether they are 
called investors or evaluators, must choose among many possible ventures. To arrive at a 
decision, assessors use past performance, current leadership, infrastructure, location, 
feasibility, collaborators, and partners, and, of course, the expected return on investment 
money. Unlike investors, evaluators do not directly benefit from their investments; after all, it 
is not their money, so they are more like investment consultants. As such, they have a 
fiduciary duty to try to obtain the greatest return (impact) for the grant agency’s money [10]. 
Funding agencies generally are aware that, as in investing, greater risk increases both 
the potential reward and the possibility of failure. Innovation is essential to scientific 
progress, but it is also inherently risky. Hence, agencies often have specific programmes 
aimed at high-risk, innovative research. High-risk funding programmes might specifically 
cater to risky research projects, people who wish to work outside the comfort of their usual 
research groups or fields, individuals as opposed to groups, and tangential ideas and projects. 
In contrast, low-risk funding programmes might include continuing funding, institutional 
funding that must be awarded, and funding to large or politically well-connected groups that, 
realistically, would not be denied funding.  
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National granting agencies invite, accept, assess, and fund research proposals 
throughout the year. By necessity, some programmes are tied to specific times of the year, 
sometimes linked to academic or fiscal calendars, and other programmes are scattered across 
the year. However, the timing of purposefully high-risk programmes usually does takes into 
account the fact that proposal writers, and perhaps more importantly, the expert reviewers 
who evaluate the proposals, and agency officials who eventually make the funding decisions, 
might all be influenced by SAD. 
 
Granting agencies in high latitude countries must be careful to time these “high-risk”, 
“innovative research” competitions such that they are not written or evaluated during the SAD 
months. During the late fall, November and December, as days become increasingly shorter, 
people might very well be walking around in a darkness-induced state of mild depression. As 
such, they would be more likely to opt for safe investments, more of the same, the well 
established, which is the antithesis of innovative research. In high-latitude countries, 
submitting and, perhaps more importantly, evaluating high-risk, innovative, proposals during 
the late fall might significantly detract from the very purpose of such programmes. 
 
SAD can affect both the process of reviewing and the act of writing a research 
proposal. As long as the call for proposals is made sufficiently in advance, there is no way of 
knowing when exactly the proposals are written and the main ideas are generated. However, a 
proposal’s final review would probably be close to the submission deadline. If that 
submission deadline is during the SAD months, there is a higher likelihood that the proposal 
writers would remove the bolder, riskier, and perhaps most innovative parts of their proposals. 
A particularly interesting situation might occur when purposely high-risk proposals are 
written during the SAD months and evaluated in the spring, or vice-versa. In any case, 
granting agencies in high latitude countries might have to ensure that neither the evaluation 
nor the submission deadlines of “high” risk proposals coincides with the SAD months. 
 
In confirming this hypothesis, one must assess both the mean impact of the funded 
proposals, and the variance of that impact. Proposals funded by high risk programmes would, 
by design, include atrociously dismal failures and surprisingly wonderful successes. Hence, if 
the programme is serving its purpose, the mean impact might be the same, but the variance 
would be higher. A possible test of this idea might involve comparing instances when the 
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same competition is conducted at two times of the year, and assessing the eventual impact of 
the funded proposals. Alternatively, one could search for instances when then timing of the 
evaluation and/or submission deadline of a particular programme has changed, and examine 
the impact of the said research before and after the change. In the lab, it is possible to carry 
out controlled experiments whereby proposals could be evaluated at different times of the 
year by the same, or by different people. As always, each approach has distinct strengths and 
weaknesses. 
The effects of SAD have been documented in investing, but not yet in grantmanship. 
However, just like entrepreneurs and investors, researchers and evaluators are not necessarily 
immune to the effects of SAD. If the effects are similar, and there is no reason why they 
should not be, it would be easy for granting agencies change the of submission and evaluation 
times for competitions for research that is specifically meant to be high-risk, just to be safe. 
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